Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,285 across all filing types
Latest filing 2020-07-01 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
第四届董事会第二十三次会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board meeting regarding the company's plan to issue convertible bonds to unspecified investors. It includes detailed terms of the convertible bonds, such as issuance scale, interest rates, conversion price adjustments, redemption and repurchase clauses, use of proceeds, and authorization requests for the board to handle related matters. The document also mentions that these proposals require shareholder approval at a forthcoming extraordinary general meeting. The content is focused on capital raising and financing activities, specifically the issuance of convertible bonds, and is not a financial report, earnings release, or management discussion. It is not a simple announcement of voting results but a comprehensive update on financing plans and related board resolutions. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a regulatory filing. Confidence is high due to the extensive financing details and board resolutions related to convertible bond issuance.
2020-07-01 Chinese
关于最近五年被证券监管部门和交易所采取监管措施或处罚及整改情况的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Tianjin Ruipu Biotechnology Co., Ltd. regarding regulatory measures and penalties taken by securities regulatory authorities and exchanges over the past five years, along with the company's rectification status. It details specific regulatory letters, court rulings, and corrective actions related to financial support and overdue repayments. The document is relatively short (2160 characters) and focuses on regulatory compliance and enforcement history rather than presenting financial statements or detailed financial performance. It does not contain financial data or results but is a disclosure of regulatory history and corrective measures. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2020-07-01 Chinese
关于向不特定对象发行可转换公司债券摊薄即期回报对公司主要财务指标的影响及公司采取措施和相关主体承诺的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement by Tianjin Ruipu Biological Technology Co., Ltd. regarding the issuance of convertible bonds to unspecified investors. It includes an analysis of the impact of this issuance on the company's key financial indicators, assumptions used for the analysis, risk warnings, the necessity of the financing, the relationship of the investment projects to existing business, measures to mitigate dilution of immediate returns, and commitments by the board and controlling shareholders. The document references regulatory requirements from the China Securities Regulatory Commission and Shenzhen Stock Exchange, and discusses financial metrics and projections in detail. It is not a full annual or interim report, nor an earnings release or audit report. It is not a simple announcement of a report publication but a substantive disclosure about capital raising and its financial impact. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising activities and capital structure changes, including detailed financial impact analysis and management commitments.
2020-07-01 Chinese
截至2020年3月31日止的前次募集资金使用情况报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "前次募集资金使用情况报告" which translates to "Report on the Use of Previous Fundraising Proceeds". It references regulatory requirements from the China Securities Regulatory Commission and details the use of funds raised in a prior non-public stock issuance, including amounts raised, usage, investment projects, and economic benefits realized. The document is focused on the status and use of previously raised capital rather than announcing new financing or capital changes. It is not an announcement of a report publication but the report itself, given the detailed financial and project usage data. This fits the category of a Capital/Financing Update (CAP) as it provides an update on the use of capital raised in a prior financing event, consistent with the definition of CAP filings which cover updates on company fundraising and capital structure changes. The document length is 4067 characters, which is sufficient for a substantive report rather than a brief announcement. Therefore, the best classification is CAP with high confidence.
2020-07-01 Chinese
内部控制鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as an "内部控制鉴证报告" which translates to "Internal Control Assurance Report". It is issued by an accounting firm and addresses the effectiveness of internal controls related to financial reporting for the fiscal year ending December 31, 2019. The document includes detailed evaluation of internal control systems, management responsibilities, auditor responsibilities, and conclusions on internal control effectiveness. It also contains an internal control self-evaluation report by the company. The content is focused on internal control audit and assurance rather than a full annual report or financial statements. This matches the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles. The document is 6664 characters long, which is sufficient to be a full report rather than a brief announcement. Therefore, the appropriate classification is AR with high confidence. FY 2019
2020-07-01 Chinese
未来三年（2020年-2022年）股东回报规划
Capital/Financing Update Classification · 95% confidence The document is titled as a "Future Three-Year (2020-2022) Shareholder Return Plan" issued by the Board of Directors of Tianjin Ruipu Biotechnology Co., Ltd. It outlines the company's policy and principles for shareholder returns, including cash dividends and stock dividends, conditions for distribution, and decision-making procedures. The content is a strategic plan or policy document related to dividends and shareholder returns rather than an announcement of dividend amounts or payment dates. It is not a financial report, earnings release, or regulatory filing. It is also not a notice of dividend amount (DIV) because it does not specify actual dividend amounts or payment dates but rather a multi-year plan for shareholder returns. The document is a formal plan issued by the board, so it fits best under Capital/Financing Update (CAP) as it relates to the company's capital distribution policy and financing strategy for shareholder returns over multiple years.
2020-07-01 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.